Streetbeat News

Stock Prices

QLYS

Qualys has projected its Q4 2023 adjusted EPS to be between $1.18 and $1.28, which is higher than the estimated $1.12. The company also expects its revenue to be between $144.1M and $145.1M, slightly below the estimated $145.16M.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:34 pm

REG

Regency Centers has revised its 2023 Nareit FFO per share outlook from $4.11-$4.15 to $4.13-$4.15.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:34 pm

AMH

American Homes 4 Rent has updated its FY23 guidance, expecting an incremental Core FFO/Share of $0.01. This is primarily due to increased Core NOI growth from both same-home and non-same-home portfolios.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:32 pm

AAPL

FXI

Apple's CEO, Tim Cook, announced during a conference call that the iPhone set a September quarter record in mainland China.

Portfolio Pulse from Charles Gross

November 02, 2023 | 9:31 pm

BZFD

GDEV

IAS

LLYVK

LQR

LUMN

MGNI

MMV

PARA

PARAP

PODC

YELP

Several communication services stocks experienced significant movement in Thursday's after-market session. Gainers included Integral Ad Science (NASDAQ:IAS), Paramount Global (NASDAQ:PARAP), PodcastOne (NASDAQ:PODC), Paramount Global (NASDAQ:PARA), Magnite (NASDAQ:MGNI), and Yelp (NYSE:YELP). Losers included BuzzFeed (NASDAQ:BZFD), LQR House (NASDAQ:LQR), Lumen Technologies (NYSE:LUMN), MultiMetaVerse Holdings (NASDAQ:MMV), Liberty Live (NASDAQ:LLYVK), and GDEV (NASDAQ:GDEV). Q3 earnings reports were released for several of these companies.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 9:31 pm

AGL

DMTK

Several healthcare stocks experienced significant movement in Thursday's after-market session. DermTech, Ekso Bionics Holdings, Definitive Healthcare, Durect, Castle Biosciences, and Reshape Lifesciences saw increases, with DermTech leading with a 23.6% rise. On the other hand, Agilon Health, AbCellera Biologics, Impel Pharmaceuticals, Penumbra, Bright Green, and Galera Therapeutics experienced decreases, with Agilon Health leading the losses with a 15.6% drop. Most of these movements were associated with the release of Q3 earnings reports.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 9:31 pm

HLIO

PCTY

WSC

Several industrial stocks experienced significant movement in Thursday's after-market session. Notable gainers included WillScot Mobile Mini (WSC), Barnes Gr (B), Innodata (INOD), Pioneer Power Solutions (PPSI), Astra Space (ASTR), and CBAK Energy Tech (CBAT). On the other hand, Paylocity Holding (PCTY), WANG & LEE Group (WLGS), Helios Technologies (HLIO), Heliogen (HLGN), Broadwind (BWEN), and Mynaric (MYNA) saw their stocks fall.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 9:31 pm

AEYE

BILL

DOCN

FTNT

Several IT stocks experienced significant movement in Thursday's after-market session following the release of their Q3 earnings reports. Gainers included DigitalOcean Holdings (DOCN), AudioEye (AEYE), Sprout Social (SPT), Maxeon Solar Technologies (MAXN), T Stamp (IDAI), and Intrusion (INTZ). Losers included BILL Holdings (BILL), Inseego (INSG), Fortinet (FTNT), Atlassian (TEAM), Appian (APPN), and Cloudflare (NET).

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 9:31 pm

NVO

Novo Nordisk (NYSE:NVO) has outperformed the market over the past 5 years by 26.77% on an annualized basis, producing an average annual return of 36.15%. If an investor had bought $1000 of NVO stock 5 years ago, it would be worth $4,659.74 today.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 9:30 pm

Canadian Pacific Kansas (NYSE:CP) has outperformed the market over the past 20 years, producing an average annual return of 13.54%. If an investor had bought $1000 of CP stock 20 years ago, it would be worth $12,675.30 today.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 9:30 pm